Endogenous biochemical regulation of diurnal changes in intraocular pressure was investigated in rabbits. Various biochemical parameters in eye tissues, particularly the iris and ciliary body, were studied at peak (21:00 hr) and trough (09 :00 hr) points of IOP. No statistical difference in choline acetyltransferase activity, adrenergic transmitter levels and dopamine concentration could be detected at these points. On the other hand, serotonin N-acetyltransferase activity was significantly higher at 21:00 hr (2.84 ± 0.14 nmoles/mg protein/hr) than at 09:00 hr (2.18 ± 0.16 nmoles/mg protein/hr) indicating that melatonin might be involved in the diurnal changes in IOP. Intracameral injections of various agents into rabbit eyes revealed that melatonin but not serotonin nor N-acetylserotonin raised IOP markedly, indicating that melatonin but not its precursors is involved in IOP regulation. Topical application of melatonin did not affect the IOP presumably because it does not cross the cornea effectively.

Keywords:
Diurnal changes, Intraocular pressure, N-acetyltransferase, Melatonin, Iris-ciliary body, Serotonin, N-acetylserotonin, Catecholamines
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.